SEC Form 4 · accession 0001127602-17-010145
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig E Samitt
Officer — EVP & Chief Clinical Officer
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2017 | F | 408 | $166.97 | D | 6,000 | D | |
| Common StockF2 | Mar 1, 2017 | A | 3,369 | $0.00 | A | 9,369 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $166.97 | Mar 1, 2017 | A | 13,782 | A | — | Mar 1, 2027 | Common Stock | 13,782 | 13,782 | D |
Explanation of responses
- F1PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- F2Represents restricted share units. Restrictions lapse as follows: 1,123 shares each on 3/1/2018, 3/1/2019 and 3/1/2020.
- F3The option represents a right to purchase a total of 13,782 shares, and is exercisable in six semi-annual installments of 2,297 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.